Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: Potential role of IL-6 in neuropathic pain

Molecular Brain Research

Volumn 62, Issue 2, 1998, Pages 228-235

  Arruda, Janice L ^a   Colburn, Raymond W ^b   Rickman, Amy J ^a   Rutkowski, Maria D ^a   DeLeo, Joyce A ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Allodynia; Immune response; In situ hybridization; Interleukin 6; Nerve injury

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RNA ANALYSIS; SPINAL CORD;

ANIMALS; CAUSALGIA; COLD; GENE EXPRESSION REGULATION; HYPESTHESIA; IN SITU HYBRIDIZATION; INTERLEUKIN-6; LIGATION; MALE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL NERVES;

EID: 0032570035     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00257-5     Document Type: Article

References (46)

1. Akaneya Y., Takahashi M., Hatanaka H. Interleukin-1β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Expl. Neurol. 136:1995;44-52.
2. Beck J.T., Hsu S.M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N.E. J. Med. 330:1994;602-605.
3. Bolin L.M., Verity A.N., Silver J.E., Shoot E.M., Abrams J.S. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64:1995;850-858.
4. Brakenhoff J.P.L., Dehon F.D., Fontaine V., Tenboekel E., Schooltink H., Rose-John S., Heinrich P.C., Content J., Aarden L.A. Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269:1994;86-93.
5. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inflis J.D., Oldstone M.B.A., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10061-10065.
6. Chiang C., Stalder A., Samimi A., Campbell I.L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16:1994;212-221.
7. Ciapponi L., Maione D., Scoumanne A., Costa P., Hansen M.B., Svenson M., Bendtzen K., Alonzi T., Paonessa G., Cortese R., Ciliberto G., Savino R. Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist. Nature Biotechnol. 15:1997;997-1001.
8. R.W. Colburn, J.A. DeLeo, A.J. Rickman, The effect of site versus type of nerve injury on glial activity and behavior in the rat, Exp. Neurol., submitted for publication.
9. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J. Neuroimmunol. 79:1997;163-175.
10. J.A. DeLeo, R.W. Colburn, The role of cytokines in nociception and chronic pain, in: J. Weinstein, S. Gordon (Ed.), Low Back Pain: A Scientific and Clinical Overview. American Academy of Orthopaedic Surgeons, Rosemont, Illinois, 1996, pp. 163-185.
11. DeLeo J.A., Colburn R.W., Nichols M., Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16:1996;695-700.
12. P.C. Emson, M.J Gait, In situ hybridization with biotinylated probes, in: D.G. Wilkinson (Ed.), In Situ Hybridization A Practical Approach, The Practical Approach Series, New York, NY, 1992, pp. 45-59.
13. Fann M.J., Patterson P.H. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl. Acad. Sci. U.S.A. 91:1994;43-47.
14. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7:1995;2441-2449.
15. 2/B-cell stimulating factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the acute phase response in liver cells. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7251-7259.
16. Geiss A., Varadi E., Steinbach K., Bauer H., Anton F. Psychoneruoimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci. Lett. 237:1997;65-68.
17. Gijbels K., Brocke S., Abrams J.S., Steinman L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:1995;795-805.
18. Goodman M.N. Interleukin-6 induces skeletal muscle breakdown in rats. Proc. Soc. Exp. Biol. Med. 205:1994;182-185.
19. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
20. Hama T., Miyamoto M., Tsukui H., Nishio C., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104:1989;340-344.
21. Hariri R.J., Chang V.A., Barie P.S., Wang R.S., Sharif S.F., Ghajar J.B.G. Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res. 636:1994;139-142.
22. Hirohata H., Kiyama H., Kishimoto T., Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin 6 (IL-6) and IL-6 receptor after trauma. J. Expl. Med. 183:1996;2627-2634.
23. Ikeda K., Iwasaki Y., Shiojima T., Kinoshita M. Neuroprotective effects of various cytokines on developing spinal motoneurons following axotomy. J. Neurol. Sci. 135:1996;109-113.
24. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., Manolagas S.C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:1992;88-91.
25. Kiefer R., Lindholm D., Kreutzberg G.W. Interleukin-6 and transforming growth factor beta1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci. 5:1993;775-781.
26. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
27. Klein B., Wijdenes J., Zhang X.G., Jourdan M., Boiron J.M., Brochier J., Liautard J., Merlin M., Clement C., Morel-Fournier B.et al. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 78:1991;1198-1204.
28. Klein M.A., Moller J.C., Jones L.L., Bluethmann H., Kreutzberg G.W., Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 19:1997;227-233.
29. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bleuthmann H., Kohler G. Impaired immune and acute phase responses in interleukin-6 deficient mice. Nature. 368:1994;339-342.
30. Kushima Y., Hatanaka H. Interleukin-6 and leukiemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci. Lett. 143:1992;110-114.
31. Lee F.D. The role of interleukin-6 in development. Dev. Biol. 151:1992;331-338.
32. J.D. Loeser, M.J. Cousins, Contemporary pain management, Med. J. Australia, 153 (1990) 208-212, 216.
33. Marz P., Herget T., Lang E., Otten U., Rose-John S. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. 12:1997;2765-2773.
34. Murphy P.G., Grondin J., Altares M., Richardson P.M. Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. 15:1995;5130-5138.
35. Nakafuku M., Satoh T., Kaziro Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active ras-GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 267:1992;19448-19454.
36. Oka T., Oka K., Hosoi M., Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692:1995;123-128.
37. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Cilibetto G., Rodan G.A., Costantini F. Interleukin-6 deficient mice are protected from bone loss by estrogen depletion. EMBO J. 13:1994;1189-1196.
38. Savino R., Lahm A., Salvati A.L., Ciapponi L., Sporeno E., Altamura S., Paonessa G., Toniatti C., Ciliberto G. Generation of interleukin-6 receptor antagonists by molecular modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13:1994;1357-1367.
39. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNFα and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14:1994;615-619.
40. Steffensen S.C., Campbell I.L., Henriksen S.J. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652:1994;149-153.
41. Streit W.J. Microglial-neuronal interactions. J. Chem. Neuroanat. 6:1993;261-266.
42. Suzuki H., Yasukawa K., Saito T., Goitsuka R., Hasegawa A., Ohsugi Y., Taga T., Kishimoto T. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur. J. Immunol. 22:1992;1989-1993.
43. Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic behaviors. Neuroreport. 7:1996;2897-2901.
44. Willenbring S., DeLeo J.A., Coombs D.W. Differential behavioral outcomes in the sciatic cryoneurolysis model of neuropathic pain in rats. Pain. 58:1994;135-140.
45. Woodroofe M.N., Sarna G.S., Wadha M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33:1991;227-236.
46. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.